Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar

BACKGROUND: Tuberculosis is considered the second most common cause of death due to infectious agent. The currently preferred regimen for treatment of pulmonary tuberculosis (PTB) is isoniazid, rifampin, pyrazinamide, and ethambutol, which has been used either as separate tablets (ST) or as fixed-do...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Shaer, Mohammad H., Mansour, Hanine, Elewa, Hazem, Salameh, Pascale, Iqbal, Fatima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290647/
https://www.ncbi.nlm.nih.gov/pubmed/28152986
http://dx.doi.org/10.1186/s12879-017-2231-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290647/
https://www.ncbi.nlm.nih.gov/pubmed/28152986
http://dx.doi.org/10.1186/s12879-017-2231-1

Ejemplares similares